The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement is to invite applications for innovative clinical, and preclinical/translational research to develop therapeutic vaccine strategies to improve treatment outcomes of active tuberculosis (TB) in the presence or absence of HIV co-infection.
- Letter of Intent Due Date(s): 30 days prior to the application due date
- AIDS Application Due Date(s): July 28, 2020
RFA-AI-20-010 Expiration Date July 29, 2020
The scope of the proposed project should determine the project period. The maximum project period is 5 years.